• Canada Approves At-home Entyvio Injection for Crohn’s
  • My COVID-19 Vaccine Experience, Part 1: Expectations and Frustrations
  • Risankizumab for 12 Weeks Leads to Remission in Crohn’s Trials
  • Nurturing Hope in 2021 With Fertilizer From 2020
  • Clinical Benefits of ABX464 for Ulcerative Colitis Revealed in Review Study
  • Finding a Remedy When Remicade Stops Working
  • EU Reviewing Zeposia as Ulcerative Colitis Treatment for Adults
  • Rinvoq Found Safe, Effective for Ulcerative Colitis in Ongoing Phase 3 Trial
  • Abivax Completes Enrollment in ABX464 Trial for Ulcerative Colitis
  • Chicken Soup for the Soul and IBD Symptoms
  • A Week of Worry: COVID-19 Hits Home
  • Takeda Partners With Universities on Research Into GI and Liver Disorders